×

Strengthening the Commonwealth’s Innovation Pipeline: A Policy Analysis of the Seventy-Five Percent Research and Development Tax Credit Liability Limitation for Massachusetts Small and Medium Businesses

Author: Lismar Serafini | Massachusetts R&D Tax Policy Consultant
Published: July 31, 2026 | Series: Swanson Reed State Tax Incentives

Answer Capsule: How Does the 75% Limitation Act as a “Success Tax” on Scaling SMBs?

Under M.G.L. c. 63, § 38M(e), Massachusetts artificially restricts the utility of the R&D tax credit by mandating that it cannot offset more than 75% of corporate excise liability above a static $25,000 threshold. For scaling Small and Medium Businesses (SMBs) just entering profitability, this limitation functions as a severe “success tax”—draining their operational cash flow precisely when capital is most needed for expansion. To prevent these firms from relocating commercial operations to competitor states, the Massachusetts Legislature must implement a Tiered Offset System (raising the 100% threshold from $25K to $250K for SMBs) or establish a targeted “Innovation Voucher” program to refund trapped credits.

Key Takeaways

  • The Mechanics of the Trapped Credit: While early-stage R&D credits can be carried forward indefinitely if limited by the 75% rule, they provide zero immediate liquidity. Scaling SMBs are forced to pay 25% of their excise tax in cash, diverting vital funds away from hiring and laboratory expansion.
  • The Regional Disadvantage: Regional competitors like New York and Connecticut offer, or are aggressively proposing, fully refundable models with massive offset caps (up to $500K or $1.5M annually) that drastically outperform the antiquated $25,000 Massachusetts threshold.
  • Proposed Solution 1 (Threshold Modernization): Legislatively index the outdated $25,000 baseline to inflation and create a “Small Business Innovation Tier” that permits SMBs (<150 employees or <$50M gross receipts) to fully offset up to $250,000 in corporate excise.
  • Proposed Solution 2 (Growth-Stage Voucher): Establish an Executive Office of Economic Development “Innovation Voucher” granting scaling non-life science firms up to a 90% refund on trapped credits, conditionally tied to strict Gateway City capital investments and job creation metrics.
  • Fraud Mitigation & Clawbacks: Pair expanded liquidity with a rigorous GAO-based fraud risk framework, requiring third-party CPA verification for large offsets and robust statutory clawbacks if a firm utilizes the tax relief but subsequently fails to meet its Massachusetts employment commitments.

1. Executive Summary

The economic identity of Massachusetts is inextricably linked to the success of its knowledge-based industries. As a global leader in life sciences, biotechnology, advanced manufacturing, and climatetech, the Commonwealth has constructed a sophisticated ecosystem of innovation that relies on a symbiotic relationship between world-class academic research and a pro-growth corporate tax environment. Central to this environment is the Massachusetts Research and Development (R&D) Tax Credit, established under Massachusetts General Law (M.G.L.) Chapter 63, Section 38M. While this credit has historically served as a vital anchor for high-tech firms, a specific structural constraint—the seventy-five percent liability limitation—presents an increasingly significant hurdle for small and medium-sized businesses (SMBs) as they transition from the research phase to commercial profitability. This limitation, which restricts the amount of credit a corporation can use to offset its excise tax in any single year, creates a “trapped credit” phenomenon that diminishes the immediate liquidity of scaling firms.

2. The Framework of the Massachusetts Research and Development Tax Credit

The Massachusetts R&D credit was designed to mirror the federal credit available under Section 41 of the Internal Revenue Code (IRC), yet it incorporates unique state-specific parameters aimed at incentivizing local investment. Under the current statutory framework, the credit is available to business corporations subject to the corporate excise tax and to owners of flow-through entities who conduct qualified research activities within the Commonwealth. To ensure that the benefits of the credit accrue to the state’s economy, the statutes require that all qualifying research must be performed within the geographic boundaries of Massachusetts.

Core Components and Calculation Methodologies

The calculation of the Massachusetts R&D credit is bifurcated into two primary streams: a credit for incremental research expenses and a credit for basic research payments made to qualified organizations. The regular credit is equal to the sum of 10 percent of the excess of qualified research expenses (QREs) over a base amount, plus 15 percent of basic research payments made to universities, hospitals, and other non-profit research organizations.

The definition of “qualified research expenses” follows the federal standard, including wages paid to employees directly engaged in or supporting research, the cost of supplies consumed during the research process, and 65 percent of payments made to third-party contractors for research performed in-state. Furthermore, the state provides an Alternative Simplified Credit (ASC) option, which has become particularly popular among SMBs due to its reduced administrative complexity. Under the ASC method, firms can claim a credit equal to 10 percent of the current year’s QREs that exceed 50 percent of the average QREs from the preceding three taxable years.

Table 1: Comparison of Massachusetts R&D Credit Rates and Calculation Methodologies

Calculation Component Regular Method Rate ASC Method Rate Qualifying Base
Incremental Qualified Research Expenses (QREs) 10% 10% Excess over Base Amount or 50% of 3-year Average
Basic Research Payments (BRPs) 15% N/A Total Payments to Qualified Institutions
New Taxpayer (No prior 3-year history) N/A 5% Flat Percentage of Current Year QREs

The Statutory Definition of Qualified Research

For an activity to qualify for the credit, it must satisfy the federal “four-part test” incorporated into Massachusetts law. First, the research must be intended to discover information that is technological in nature, relying on principles of physical or biological science, engineering, or computer science. Second, the activity must relate to a “permitted purpose,” such as developing a new or improved business component’s functionality, performance, reliability, or quality. Third, the research must aim to eliminate technical uncertainty regarding the capability, method, or design of a product or process. Finally, the taxpayer must engage in a process of experimentation, which typically involves the evaluation of alternatives through modeling, simulation, or systematic trial and error.

3. The Seventy-Five Percent Liability Limitation: Origins and Mechanics

The primary policy challenge addressed in this report is the limitation set forth in M.G.L. c. 63, § 38M(e). This provision dictates that the R&D credit may not reduce a corporation’s excise tax by more than 100 percent of the first $25,000 of excise liability, plus 75 percent of any excise liability that exceeds $25,000. This restriction ensures that even the most innovative and credit-rich corporations are required to pay at least a portion of their tax liability in cash each year.

The Mechanics of the “Trapped Credit”

The 75 percent rule functions as a constraint on the utility of the credit rather than a cap on the amount of credit that can be earned. When a corporation’s calculated R&D credit exceeds the allowable offset for a given year, the unused portion is not lost but is instead categorized for future use. The treatment of these “trapped” credits depends on why they could not be used. If the credits were disallowed specifically because of the 75 percent rule, they can be carried forward indefinitely. If they were disallowed because the total credit amount simply exceeded the total tax liability, they are subject to a 15-year carryforward period.

While the indefinite carryforward for credits capped by the 75 percent rule provides long-term value, it does little to alleviate the immediate cash flow pressures faced by SMBs. For a scaling company that is reinvesting every dollar into hiring or new laboratory equipment, the requirement to pay 25 percent of its tax bill above the $25,000 threshold represents a significant diversion of capital.

Impact on Combined Groups

The 75 percent limitation is particularly complex for corporations filing as part of a combined group. Under Massachusetts law, a combined group is entitled to only a single $25,000 threshold, which must be apportioned among the members of the controlled group. This aggregation rule prevents large entities from multiplying their $25,000 full-offset thresholds by creating numerous subsidiaries. For SMBs that may be part of a small group of related entities, this shared threshold further restricts the immediate tax relief available to the individual member corporations.

4. The Policy Issue in the SMB Context: The “Success Tax” on Growth

For a small business in the pre-revenue or early-revenue phase, the R&D credit may offer limited immediate utility unless the firm is a certified life sciences company eligible for refundability. However, as an SMB successfully commercializes its technology and begins to generate taxable income, it enters a critical growth phase where the 75 percent limitation begins to bite. In this context, the limitation acts as a “success tax” that punishes firms for becoming profitable and scaling their operations in Massachusetts.

Cash Flow Constraints and the Capital Intensity of R&D

Innovation in sectors like biotechnology, medical devices, and advanced propulsion is notoriously capital-intensive. SMBs in these fields often operate with thin margins as they scale production and expand their workforce. The 75 percent limitation essentially mandates that 25 percent of the state’s tax on their innovative success must be paid in cash, regardless of how much they have invested in local R&D. This cash outflow can be the difference between hiring a new research scientist or delaying a critical project.

The economic multiplier of R&D investment in Massachusetts is significant. Every dollar of research funding in the state creates nearly double the amount of economic activity. By restricting the reinvestment of these tax savings, the 75 percent rule effectively dampens this multiplier effect. Furthermore, Massachusetts is home to one in every ten R&D jobs in the United States, yet only one in 40 of all US jobs. This concentration of innovation talent means that any policy that hinders the growth of R&D-heavy SMBs has a disproportionate impact on the Commonwealth’s overall economic health.

Entity Structure and the Pass-Through Disadvantage

The impact of the 75 percent limitation also varies significantly based on the legal structure of the business. For C-corporations, the credit is applied at the entity level against the corporate excise. For S-corporations, the credit is likewise applied at the entity level and does not pass through to shareholders. This is a critical distinction; while many other tax credits pass through to individual owners, the Massachusetts R&D credit remains locked at the corporate level, where it remains subject to the 75 percent cap and the $456 minimum tax.

Conversely, for unincorporated entities like partnerships and LLCs, the credits are attributed to the owners and can be taken against their personal tax liabilities. However, these individual owners may still face limitations based on their own tax situations, and the complexity of allocating these credits can be an administrative burden for smaller firms.

Table 2: Application of R&D Tax Credits by Entity Structure

Entity Type Credit Application Level Impact of 75% Rule Pass-Through to Owners
C-Corporation Entity Level Subject to $25k/75% Cap No
S-Corporation Entity Level Subject to $25k/75% Cap No
Partnership / LLC Individual Level Factored into owner liability Yes

5. Proposed Solution I: Modernizing the Statutory Threshold for SMBs

The first practical solution for the Massachusetts legislature is to modernize the $25,000 threshold for full credit offset. This threshold has not been adjusted for inflation or economic growth in decades, meaning that more and more SMBs are falling into the 75 percent limitation zone simply due to the increased nominal costs of operating in the modern economy.

Tiered Offset Thresholds Based on Company Size

The legislature could implement a tiered system that increases the 100 percent offset threshold for businesses that meet certain size criteria. For example, a “Small Business Innovation Tier” could be established for corporations with fewer than 150 employees or annual gross receipts below $50 million. For these firms, the 100 percent offset threshold could be increased from $25,000 to $250,000.

This change would allow a vast majority of the state’s high-growth SMBs to utilize their R&D credits in full, providing them with immediate cash liquidity to reinvest in their Massachusetts operations. For the state, the fiscal impact would be partially offset by the fact that these credits are already being earned and carried forward; accelerating their use does not increase the total amount of credits awarded, but rather shifts the timing of the tax expenditure to a period where it can more effectively spur growth.

Indexing the Threshold for Inflation

To prevent the future erosion of the credit’s value, the legislature should mandate that the full-offset threshold (currently $25,000) be indexed annually to the Consumer Price Index (CPI) or a similar inflation metric. This ensures that as the costs of research and development—particularly wages—rise, the tax code remains aligned with the economic reality of innovation-based firms.

6. Proposed Solution II: The “Growth-Stage” Credit Monetization Program

The second practical solution involves creating a mechanism for non-life sciences SMBs to monetize a portion of their “trapped” R&D credits, similar to the voucher programs recently proposed in Connecticut or the existing programs for life sciences firms in Massachusetts.

Refundable Voucher Program for Targeted Sectors

The state could establish an “Innovation Voucher” program administered by the Executive Office of Economic Development. Under this program, SMBs that have accumulated credits disallowed by the 75 percent rule could apply to receive a refund of up to 90 percent of the credit’s value, provided the funds are reinvested into specific growth activities. This program could be targeted toward priority sectors such as climatetech, artificial intelligence, and advanced manufacturing, ensuring that the state is actively supporting the next generation of industrial leaders.

To ensure that the state receives a tangible return on this investment, the voucher program should be contingent on:

  • Net New Job Creation: Requiring the firm to create and maintain a minimum number of full-time equivalent positions in Massachusetts for at least three years.
  • Capital Investment in Gateway Cities: Providing a higher monetization rate for firms that invest in facilities or equipment in Massachusetts’ Gateway Cities, thereby supporting regional economic equity.

7. Implementation Strategy: Balancing Benefit with Program Integrity

A significant concern for any tax policy change is the risk of fraud, waste, and abuse. To benefit SMBs while protecting taxpayer interests, the Massachusetts government must implement the proposed changes within a rigorous governance framework.

Adopting the GAO Fraud Risk Management Framework

The Massachusetts Department of Revenue (DOR) should adopt the leading practices identified by the US Government Accountability Office (GAO) for managing fraud risk. This framework involves four key components: committing to a culture of integrity, assessing specific fraud risks, designing and implementing control activities, and evaluating outcomes.

The implementation of the increased offset threshold or the monetization program should include:

  • Dedicated Entity for Fraud Management: Establishing a specialized unit within the DOR or the Office of Economic Development to oversee the certification of SMBs for the enhanced credit.
  • Enhanced Data Analytics: Using data matching between DOR tax filings and Department of Unemployment Assistance (DUA) payroll records to verify that the wages claimed for the credit were actually paid to individuals working in Massachusetts.
  • CPA-Verified Reports: Requiring businesses to submit a report verified by a third-party Certified Public Accountant (CPA) when applying for the enhanced offset threshold or credit monetization. This places the burden of initial validation on the private sector while providing the state with reliable data for its own audits.

Clawback Provisions for Non-Compliance

To ensure that firms do not simply take the tax benefits and then move their operations out of state, the legislature must include robust “clawback” provisions. These provisions would allow the state to recover the value of the tax relief if a company fails to meet its job creation or investment commitments within a specified timeframe, typically five years. This model has been successfully employed by the Massachusetts Life Sciences Center (MLSC), which decertifies companies that fail to meet at least 70 percent of their job targets and notifies the DOR to initiate recovery procedures.

Table 3: Framework for Fraud Prevention and Program Integrity

Component of Control Strategy Objective
Verification Third-Party CPA Audit Ensure data accuracy before filing
Monitoring Annual Performance Reports Track job creation and investment metrics
Enforcement Statutory Clawbacks Recover funds from non-compliant firms
Prevention Data Matching with DUA Detect ghost employees or out-of-state wages

8. Cost Analysis: Initial Outlay vs. Long-Term Economic Dividend

A common obstacle to tax reform is the perceived near-term loss of revenue. However, for the R&D credit, the initial cost outlay should be viewed as an investment in the state’s tax base that will pay for itself through increased economic activity, payroll taxes, and long-term corporate profitability.

The Static vs. Dynamic Revenue Perspective

From a static perspective, increasing the full-offset threshold for SMBs would result in a reduction in corporate excise collections. In FY2024, Massachusetts collected approximately $4.833 billion in corporate and business taxes. While the specific revenue impact of increasing the R&D offset threshold is subject to detailed DOR modeling, current projections suggest that the “cost” is primarily a shift in timing. Because the credits disallowed by the 75 percent rule can already be carried forward indefinitely, the state is effectively holding a liability that it will eventually have to honor.

A dynamic analysis, however, accounts for the behavior of the firms receiving the relief. By providing SMBs with an additional $100,000 to $200,000 in annual liquidity, the state enables them to hire more high-salaried researchers. These employees pay personal income taxes to the Commonwealth, which are collected immediately through withholding. Furthermore, the UMass Donahue Institute has found that for every dollar of research funding, the state sees nearly double that amount in economic activity.

Calculating the Future Benefit

The long-term fiscal benefits of this policy change accrue through several channels:

  • Prevention of Migration: Retaining just one mid-sized biotech firm that might have otherwise moved to New York or Connecticut saves millions in future corporate and payroll tax revenue.
  • Accelerated Commercialization: Scaling firms reach the “tax-paying” phase of their lifecycle faster when they have the cash to resolve technical uncertainties and enter the market.
  • Infrastructure Growth: SMB expansion drives investment in lab space and manufacturing facilities, increasing local property tax bases and creating construction jobs.

By framing the policy as an investment with a 2:1 economic multiplier, the initial reduction in excise revenue is more than compensated for by the broader growth of the Massachusetts “innovation cluster”.

9. Competitive Analysis: The Threat of Regional and National Peer States

Massachusetts does not operate in a vacuum. Its innovation leadership is constantly challenged by peer states that are aggressively refining their own tax codes to attract R&D-heavy SMBs.

The New York and Connecticut Challenges

New York’s Excelsior Jobs Program and its Life Sciences R&D Tax Credit provide fully refundable credits for qualified expenditures. This means that an SMB in New York can receive cash back for its R&D even if it has zero tax liability, a massive advantage over the restrictive 75 percent rule in Massachusetts.

Connecticut is currently considering legislation (House Bill 5319 and Senate Bill 84) to expand its R&D credits to businesses with less than $70 million in gross income, specifically targeting pass-through entities. This proposal includes a voucher program and 90 percent refundability for biotech firms, specifically designed to stay competitive with Massachusetts. If Connecticut passes this legislation while Massachusetts maintains its 75 percent limitation, the regional “brain drain” of startups moving south could accelerate.

The California High-Threshold Model

California, a primary rival for technology and life sciences leadership, offers a much higher threshold for business credit limitations. While California implemented a temporary $5 million limitation on the use of business credits for certain tax years, this threshold is high enough that it has zero impact on the vast majority of SMBs. In contrast, the $25,000 threshold in Massachusetts is so low that it impacts even relatively small profitable firms, creating a significant competitive disadvantage.

Table 4: Comparative R&D Credit Attributes for Innovation Hub States

Feature Massachusetts New York Connecticut (Proposed) California
SMB Offset Limit 100% of first $25k; 75% above 100% (Up to $500k/yr) 100% (Up to $1.5M/yr) 100% (Subject to $5M general cap)
Refundability Life Sciences only Fully Refundable 65-90% Refundable Non-Refundable
Carryforward Indefinite (75% rule) 3-Year Window N/A (Voucher system) Indefinite

10. The Significance of Policy Change and the Consequences of Inaction

The Massachusetts innovation economy is currently at a crossroads. While the Commonwealth remains a leader in R&D jobs and research intensity, the national and regional landscape is shifting. The federal government’s transition under the One Big Beautiful Bill Act (OBBBA) has already created significant uncertainty regarding the timing of R&D expensing under Section 174. For Massachusetts to remain competitive, it must provide a clear, predictable, and pro-growth state tax environment.

The Risk of a “Hollowed-Out” Innovation Hub

The 75 percent limitation creates a structural incentive for firms to conduct their research in Massachusetts but move their commercial operations elsewhere once they become profitable. This “hollowing out” effect would leave the state with the high costs of supporting research (through university grants and early-stage infrastructure) without reaping the long-term tax rewards of profitable, scaling companies.

If the legislature does not address the 75 percent rule, several negative consequences are likely:

  • Loss of Mid-Market Competitiveness: SMBs are the primary engine of job growth. If these firms are disadvantaged by the tax code, they will grow more slowly, hire fewer people, and potentially be acquired by out-of-state competitors.
  • Capital Flight: Venture capital and private equity investors are sensitive to “capital efficiency.” A state tax code that traps R&D credits makes a firm less attractive to investors, potentially driving investment capital to firms in New York, California, or Texas.
  • Reduced Regional Equity: The R&D sector is one of the few that provides high-paying “blue-collar” and service jobs in sectors like construction, maintenance, and logistics. A stagnation in R&D growth hurts these working-class communities in Gateway Cities and rural areas.

11. Conclusion: A Strategic Imperative for the Legislature

The Research and Development Tax Credit is one of the most powerful tools in the Massachusetts economic development toolkit. However, like any tool, it must be maintained and modernized to remain effective. The seventy-five percent liability limitation, while originally intended as a fiscal safeguard, has become a significant obstacle for the very small and medium businesses that the state seeks to cultivate.

By increasing the full-offset threshold for SMBs and creating a monetization pathway for trapped credits, the Massachusetts legislature can unlock millions of dollars in innovation capital. When combined with a rigorous GAO-based oversight framework and robust clawback provisions, these changes can be implemented with minimal risk to the state’s fiscal stability. The cost of this reform should be viewed not as a loss, but as an essential investment in the future of the Commonwealth’s high-growth economy. Failure to act will not only stifle the growth of our most promising firms but will also signal to the global innovation community that Massachusetts is no longer the most competitive home for the technologies of tomorrow.

Notice & Disclaimer: The information is current as of July 31, 2026. This whitepaper is provided for discussion purposes only and should not be construed as legal or tax advice. It is strongly recommended that you seek professional legal or tax representation to understand how the Massachusetts R&D tax credit and any proposed policy changes would apply to specific business circumstances.
Contact Us

Send us a message and we will be in touch shortly!

Start typing and press Enter to search